Discover If You Have ADHD – Free Computer-Based Testing with Your Intake.
Happy New Year! We’re excited for a great 2026. Please send us a copy of your 2026 insurance card, and call 980-237-4766 with any questions. Remember: many deductibles reset on January 1.
Neurostar Advanced Transcranial Magnetic Stimulations (TMS) Therapy in Charlotte
When you find yourself struggling with depression that is not responding to conventional treatments like psychiatric medications and therapy, consider exploring NeuroStar Advanced Transcranial Magnetic Stimulation (TMS) in Charlotte.
NeuroStar Advanced TMS is proven depression relief with long-lasting results. 83% of patients who complete treatment experience measurable relief and 62% experience full remission of their depression symptoms** Sackeim HA, et al. (2020). J Affective Disorders, 277(12):65-74.
Partnering with Families for a Brighter Tomorrow
What is NeuroStar TMS (Transcranial Magnetic Stimulation)?
NeuroStar TMS, or Transcranial Magnetic Stimulation, is an FDA cleared treatment for the source of depression and OCD, your brain. It uses focused magnetic pulses to stimulate underactive brain nerve cells known to regulate mood, leading to improved function. Mood regulation is intricately linked to certain areas in your brain, and ”waking” up these connections can have lasting positive effects and make long-lasting remission from depression a reality.
At Pediatric & Family Behavioral Health (PFBH), NeuroStar® Transcranial Magnetic Stimulation (TMS) is delivered as a personalized, non-invasive treatment designed to target brain regions involved in mood and emotional regulation. During treatment, focused magnetic pulses are precisely guided to the left dorsolateral prefrontal cortex (DLPFC), an area commonly underactive in individuals with depression. By activating these nerve cells, TMS helps strengthen healthy brain signaling and improve how the brain processes emotions, stress, and decision making over time. As stimulation continues, connected brain networks involved in depression and OCD begin to rebalance, which can lead to meaningful symptom relief and long term improvement. PFBH proudly provides NeuroStar TMS therapy to patients in Charlotte, South Charlotte, Ballantyne, Pineville, Matthews, Fort Mill, Huntersville, and surrounding communities as part of a comprehensive mental health care approach.
Frequently Asked Questions (FAQs) About TMS
Yes, Over 7.4 million NeuroStar treatments have been performed for over 202,000 patients and real-world results show 83% of patients experience an improvement and 63% show complete remission.** Sackeim HA, et al. (2020). J Affective Disorders, 277(12):65-74. And by focusing treatment on the source of your depression, you can avoid the side effects of medications.
NeuroStar TMS is a safe, drug-free, and effective treatment for Major Depressive Disorder (MDD).
-
There is no sedation, anesthesia, or recovery time
-
It does not have the common side effects associated with traditional antidepressant medication, including insomnia, blurred vision, dry mouth, sexual dysfunction, GI distress, and more
-
It is often safe if you are taking medications for other health conditions (however, it is important to talk to a doctor to confirm Neurostar TMS is right for you)
-
You get fast results. TMS is an in-office treatment lasting as little as 19 minutes a day for seven weeks. Because TMS therapy addresses the root cause of depression, you could get your life back within two months.
Our knowledgeable team is available to answer any questions you may have about Neurostar Advanced TMS therapy, how it works, and if you are a candidate.
-
TMS treatments usually last between 19 minutes to 30 minutes for each session, and the 36 sessions are spread out over a span of 7 weeks. The initial session can last up to an hour as our TMS trained Psychiatrist performs the brain mapping (basically determining the power of the treatment and the exact location we will stimulate).
TMS involves using alternating magnetic energy to stimulate brain activity. As with any brain stimulation technology, there is a small risk of inducing a seizure. Also note Recommend to clarify that this seizure rate is in NeuroStar TMS not all TMS : Seizure risk is low with NeuroStar. The estimated risk of seizure under ordinary clinical use is approximately 1 in 30,000 treatments (0.003% of treatments) or 1 in 1,000 patients (<0.1% of patients). Other potential side effects include minor headaches, discomfort at the site of stimulation (forehead/scalp), and mild facial muscle twitching during treatment. These symptoms typically improve within a week, and only a small number of patients have discontinued treatment due to intolerable side effects. Unlike electroconvulsive therapy (ECT), TMS has not shown to have any affects on cognition. While the TMS device can be loud, we recommend wearing earplugs or listening to music during your session. Overall, TMS is a safe, non-invasive alternative to antidepressants. Unlike medications and electroconvulsive therapy, which often have significant side effects, TMS offers a path to healing without the common side effects of medication.
Transcranial Magnetic Stimulation TMS is covered by most major insurance plans for depression and OCD, and many patients qualify for low cost care, sometimes as little as $0 depending on their benefits and payer policies. Because we contract with most major insurers, our goal is to make TMS treatment affordable and accessible. Before you begin, the PFBH team will verify your coverage and provide a clear cost estimate so you know exactly what to expect.
Yes, Transcranial Magnetic Stimulation (TMS) is covered by most insurance plans that Pediatric & Family Behavioral Health (PFBH) is contracted with, including the majority of commercial insurance plans and Medicare. Coverage is typically provided once a prior authorization has been submitted and approved by your insurance carrier.
In rare cases, certain smaller or limited plans may not approve or cover TMS treatment. Based on our experience across all contracted insurers, this occurs in less than 1% of cases. Our team will verify your benefits and guide you through the authorization process before treatment begins so there are no surprises.
Pediatric & Family Behavioral Health (PFBH) partners with NeuroStar, one of the most widely used and trusted TMS platforms in the United States. NeuroStar provides specialized training and certification to our clinical staff and psychiatric providers, ensuring TMS is delivered safely, effectively, and in full compliance with all regulatory standards.
PFBH is contracted with Medicare and all major commercial insurance plans commonly used in our region, making access to insurance covered TMS in Charlotte North carolina more affordable for most patients. Additionally, PFBH is one of the only mental health organizations in North Carolina to offer TMS, psychiatric medication management, psychotherapy and counseling, and Spravato® treatment all under one roof, providing true continuity of care.
We offer TMS for depression and OCD in adults and adolescents ages 15 and older, making PFBH a leading one stop destination for comprehensive, evidence-based mental health treatment for teenagers and adults that qualify for TMS in Charlotte.
Most PFBH patients begin to notice improvements within 2 to 4 weeks of starting TMS treatment, though some of our patients feel benefits sooner and others have shown to need more time. Improvements often start gradually, such as better mood, improved sleep, increased energy, or clearer thinking, and continue to build throughout the full course of treatment. In some instances, patients start showing improvement after the 36 treatments conclude, so we always schedule a 30 day follow up appointment with your psychiatric provider to evaluate the progress and final outcome of the treatment.
TMS works cumulatively, so completing the recommended treatment schedule is important for achieving the best results. Your PFBH team will regularly monitor your progress and discuss how you’re responding so adjustments can be made if needed.
NeuroStar® TMS therapy at Pediatric & Family Behavioral Health (PFBH) is appropriate for a wide range of patients and life stages, making it a valuable option for individuals seeking effective depression or OCD treatment without additional medication. TMS is commonly used in adults, including seniors, and may be considered for adolescents (typically ages 15 and older) based on clinical evaluation and medical necessity. Because TMS does not involve systemic medications or sedation, it is often explored as a safer alternative for individuals who are sensitive to medication side effects, including older adults and patients who are pregnant or planning pregnancy, in coordination with their treating providers. With no anesthesia, no downtime, and a strong safety profile supported by years of clinical use, TMS allows patients to continue their daily routines while receiving care. At PFBH, every TMS treatment plan is carefully evaluated and monitored by trained psychiatric professionals to ensure safety, comfort, and individualized care for each patient.
Adult Indications for Use The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode. The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive Compulsive Disorder (OCD). Adolescent Indications for Use NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21). Important Safety Information NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary. The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient). Visit neurostar.com for full safety and prescribing information.